Contraception
Volume 79, Issue 4 , Pages 259-271, April 2009

Misoprostol for termination of pregnancy with intrauterine fetal demise in the second and third trimester of pregnancy — a systematic review☆☆☆

  • Rodolfo Gómez Ponce de León

      Affiliations

    • IPAS and School of Public Health, University of North Carolina at Chapel Hill, NC 28516, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 919 9605573; fax: +1 919 9297687.
    • ,
  • Deborah A. Wing

      Affiliations

    • Division of Maternal–Fetal Medicine, Department of Obstetrics–Gynecology, University of California, Irvine, CA 92868, USA

Received 17 July 2008; received in revised form 13 October 2008; accepted 15 October 2008. published online 10 December 2008.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ No financial support was received for this report.

☆☆ Dr. Wing is a principal investigator for Cytokine PharmaSciences, developer of a time-released misoprostol vaginal insert.

PII: S0010-7824(08)00490-3

doi:10.1016/j.contraception.2008.10.009

Contraception
Volume 79, Issue 4 , Pages 259-271, April 2009

Article Tools

* Image Usage & Resolution